S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
PRI   123.96 (+0.07%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
S&P 500   2,997.95 (+0.28%)
DOW   27,025.88 (+0.09%)
QQQ   193.41 (+0.19%)
AAPL   234.33 (-0.02%)
FB   189.67 (+0.06%)
MSFT   139.47 (-0.67%)
GOOGL   1,253.85 (+0.87%)
AMZN   1,790.38 (+0.73%)
CGC   20.31 (+2.94%)
NVDA   192.60 (-0.83%)
MU   45.44 (+0.62%)
BABA   176.24 (-0.50%)
GE   9.07 (+1.80%)
TSLA   262.42 (+1.03%)
AMD   31.02 (+0.68%)
T   37.78 (-0.03%)
F   9.10 (+0.33%)
ACB   3.80 (+5.27%)
PRI   123.96 (+0.07%)
NFLX   293.35 (+2.47%)
BAC   30.07 (-0.33%)
GILD   65.16 (-0.29%)
DIS   132.86 (+1.53%)
Log in

Quotient Stock Price, News & Analysis (NASDAQ:QTNT)

$7.90
+0.12 (+1.54 %)
(As of 10/17/2019 04:00 PM ET)
Today's Range
$7.77
Now: $7.90
$8.06
50-Day Range
$7.06
MA: $8.16
$9.16
52-Week Range
$5.52
Now: $7.90
$11.30
Volume179,006 shs
Average Volume342,999 shs
Market Capitalization$523.53 million
P/E RatioN/A
Dividend YieldN/A
Beta0.99
Quotient Limited, a commercial-stage diagnostics company, develops, manufactures, and commercializes conventional reagent products used for blood grouping in the transfusion diagnostics market worldwide. The company is developing MosaiQ, a proprietary technology platform, which provides tests for blood grouping and serological disease screening. Its conventional reagent products for blood grouping include antisera products that are used to identify blood-group antigens; reagent red blood cells, which enable the identification of blood-group antibodies; whole blood control products for use as daily quality assurance tests; and ancillary products that are used to support blood grouping. Read More…

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:QTNT
CUSIPN/A
Phone011-41-22-716-9800

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$29.13 million
Book Value$0.03 per share

Profitability

Net Income$-105,390,000.00
Net Margins-352.75%

Miscellaneous

EmployeesN/A
Market Cap$523.53 million
Next Earnings Date11/4/2019 (Estimated)
OptionableOptionable

Receive QTNT News and Ratings via Email

Sign-up to receive the latest news and ratings for QTNT and its competitors with MarketBeat's FREE daily newsletter.


Quotient (NASDAQ:QTNT) Frequently Asked Questions

What is Quotient's stock symbol?

Quotient trades on the NASDAQ under the ticker symbol "QTNT."

How were Quotient's earnings last quarter?

Quotient Ltd (NASDAQ:QTNT) issued its earnings results on Monday, August, 5th. The company reported ($0.36) EPS for the quarter, topping the Zacks' consensus estimate of ($0.39) by $0.03. The company earned $8.17 million during the quarter, compared to the consensus estimate of $8.40 million. View Quotient's Earnings History.

When is Quotient's next earnings date?

Quotient is scheduled to release their next quarterly earnings announcement on Monday, November 4th 2019. View Earnings Estimates for Quotient.

What guidance has Quotient issued on next quarter's earnings?

Quotient issued an update on its second quarter 2020 earnings guidance on Monday, August, 5th. The company provided EPS guidance of for the period. The company issued revenue guidance of $6.3-6.7 million, compared to the consensus revenue estimate of $6.5 million.

What price target have analysts set for QTNT?

1 brokerages have issued 1 year target prices for Quotient's shares. Their predictions range from $13.50 to $13.50. On average, they expect Quotient's share price to reach $13.50 in the next twelve months. This suggests a possible upside of 70.9% from the stock's current price. View Analyst Price Targets for Quotient.

What is the consensus analysts' recommendation for Quotient?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Quotient in the last year. There are currently 1 buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Quotient.

Has Quotient been receiving favorable news coverage?

Media coverage about QTNT stock has been trending very negative recently, InfoTrie Sentiment reports. The research group identifies positive and negative press coverage by monitoring more than six thousand news and blog sources in real time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Quotient earned a media sentiment score of -3.1 on InfoTrie's scale. They also gave news headlines about the company a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an effect on the company's share price in the next few days. View News Stories for Quotient.

Are investors shorting Quotient?

Quotient saw a increase in short interest in the month of September. As of September 30th, there was short interest totalling 4,560,000 shares, an increase of 40.3% from the August 30th total of 3,250,000 shares. Based on an average daily trading volume, of 322,700 shares, the days-to-cover ratio is currently 14.1 days. Currently, 8.0% of the company's stock are sold short. View Quotient's Current Options Chain.

Who are some of Quotient's key competitors?

What other stocks do shareholders of Quotient own?

Who are Quotient's key executives?

Quotient's management team includes the folowing people:
  • Mr. Franz Walt, CEO & Director (Age 60)
  • Mr. Jeremy Stackawitz, Pres (Age 44)
  • Mr. Edward Farrell, Pres (Age 49)
  • Mr. Christopher J. Lindop, Chief Financial Officer (Age 61)
  • Mr. John Allan, Corp. Sr. VP & CTO

How do I buy shares of Quotient?

Shares of QTNT can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Quotient's stock price today?

One share of QTNT stock can currently be purchased for approximately $7.90.

How big of a company is Quotient?

Quotient has a market capitalization of $523.53 million and generates $29.13 million in revenue each year. The company earns $-105,390,000.00 in net income (profit) each year or ($1.92) on an earnings per share basis. View Additional Information About Quotient.

What is Quotient's official website?

The official website for Quotient is http://www.quotientbd.com/.

How can I contact Quotient?

Quotient's mailing address is B1 Business Park Terre Bonne Route de Crassier 13, Eysins Y9, 1262. The company can be reached via phone at 011-41-22-716-9800.


MarketBeat Community Rating for Quotient (NASDAQ QTNT)

Community Ranking:  2.5 out of 5 (star star half star)
Outperform Votes:  258 (Vote Outperform)
Underperform Votes:  251 (Vote Underperform)
Total Votes:  509
MarketBeat's community ratings are surveys of what our community members think about Quotient and other stocks. Vote "Outperform" if you believe QTNT will outperform the S&P 500 over the long term. Vote "Underperform" if you believe QTNT will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 10/17/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel